Progressive striatal and cortical dopamine receptor dysfunction in Huntington’s disease: a PET study

ISSN： 1460-2156

Source： Brain, Vol.126, Iss.5, 2003-05, pp. : 1127-1135

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Striatal neural grafting improves cortical metabolism in Huntington’s disease patients

By Gaura Véronique

Brain, Vol. 127, Iss. 1, 2004-01 ,pp. : 65-72

Oxford University Press

Access to resources Recommend Favorite

Corticostriatal circuit dysfunction in Huntington’s disease: intersection of glutamate, dopamine and calcium

By Miller Benjamin Ray Bezprozvanny Ilya

Future Neurology, Vol. 5, Iss. 5, 2010-09 ,pp. : 735-756

Future Medicine

Access to resources Recommend Favorite

The relationship between striatal dopamine receptor binding and cognitive performance in Huntington's disease

By Lawrence AD Weeks RA Brooks DJ Andrews TC Watkins LHA Harding AE Robbins TW Sahakian BJ

Brain, Vol. 121, Iss. 7, 1998-07 ,pp. : 1343-1355

Oxford University Press

Access to resources Recommend Favorite

Striatal and extrastriatal dysfunction in Parkinson’s disease with dementia: a 6-[ 18 F]fluoro-l-dopa PET study

By Kachi T.

Brain, Vol. 125, Iss. 6, 2002-06 ,pp. : 1358-1365

Oxford University Press

Access to resources Recommend Favorite

¹⁸F-fluorodeoxyglucose-PET as a biomarker in Huntington’s disease

By Ciarmiello Andrea Squitieri Ferdinando

Neurodegenerative Disease Management, Vol. 3, Iss. 6, 2013-12 ,pp. : 489-491

Future Medicine

Access to resources Recommend Favorite